E Fund Management (HK)’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.8K Buy
287
+27
+10% +$1.53K ﹤0.01% 473
2026
Q2
$20.6K Buy
260
+65
+33% +$4.89K 0.01% 310
2026
Q1
$14.6K Buy
+195
New +$15.4K 0.01% 264

Other funds holding IONS

E Fund Management (HK)'s IONS Position: Q3 2026 in Review

E Fund Management (HK) increased its Ionis Pharmaceuticals (IONS) stake by 10% in Q3 2026, buying an estimated $1.53K and bringing the position to 287 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #473.

E Fund Management (HK) first reported a position in IONS in Q1 2026 and has held it in 3 quarters since. The position peaked at $20.6K in Q2 2026. 458 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • E Fund Management (HK) held 287 shares of Ionis Pharmaceuticals worth $12.8K as of Q3 2026.
  • E Fund Management (HK) bought 27 Ionis Pharmaceuticals shares in Q3 2026, an estimated $1.53K.
  • Ionis Pharmaceuticals made up ﹤0.01% of E Fund Management (HK)'s portfolio in Q3 2026, its #473 holding.
  • E Fund Management (HK) first reported a position in Ionis Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • E Fund Management (HK)'s Ionis Pharmaceuticals position peaked at $20.6K in Q2 2026.
  • 458 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on E Fund Management (HK)'s 13F filing for Q3 2026, filed 12 Nov 2026.